Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:50 AM
Ignite Modification Date:
2025-12-24 @ 11:50 AM
NCT ID:
NCT03212261
Eligibility Criteria:
Inclusion Criteria:
* Aged 18-64
* Within 2 years post-treatment completion for lymphoma
* English speaking
* Able and willing to provide informed consent
* Cancer treatment or follow-up for lymphoma at the MGH Cancer Center
Exclusion Criteria:
* Unwilling or unable to participate in the study
* Unable to speak or read English
* Is medically, psychiatrically, or otherwise unable to participate (as determined by a physician or study PI)
* Unwilling or unable to participate in group 3RP sessions delivered via the Partners Telehealth videoconferencing software
* Participation in qualitative interview during Phase 1 (DF/HCC 16-396)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT03212261
Study Brief:
Protocol Section:
NCT03212261